GW5074 - ≥97%, high purity , CAS No.220904-83-6, Inhibitor of Raf-1 proto-oncogene; serine/threonine kinase

Item Number

G129612

• Synonyms: Q27077947 | (3Z)-3-[(3,5-dibromo-4-hydroxy-phenyl)methylene]-5-iodo-indolin-2-one | CS-0092 | GW 5074 | Lopac0_000510 | 5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone | EC-000.2403 | NCGC00015478-01 | NCGC00015478-03 | 3-(3,5-Dibromo-4-hyd
• Specifications & Purity: Moligand™, ≥97%
• Biochemical and Physiological Mechanisms: GW5074 is a cRaf1 kinase inhibitor, which is placed immediately downstream of Ras in the Motogen activated protein kinase (MAPK) signaling pathway. It elicits protection in GW5074 prevents degeneration in Huntington′s disease and also have therapeutic pot
• Legal Information: Sold for only research purposes
• Storage Temp: Store at -20°C
• Shipped In: Ice chest + Ice pads
• Grade: Moligand™
• Action Type: INHIBITOR
• Mechanism of action: Inhibitor of Raf-1 proto-oncogene; serine/threonine kinase
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

GW 5074 is a potent and selective c-Raf inhibitor with IC50 of 9 nM, and has no effect on the activities of JNK1/2/3, MEK1, MKK6/7, CDK1/2, c-Src, p38 MAP, VEGFR2 or c-Fms